Trial Outcomes & Findings for Scaling Up Science-based Mental Health Interventions in Latin America (NCT NCT03392883)
NCT ID: NCT03392883
Last Updated: 2022-11-09
Results Overview
This measure consists of 5 scales: Adoption, Appropriateness, Acceptability, Feasibility, and Reach/Access. All four scales have a range of 1 to 4 (1- Not at all, 2- A little bit, 3- A moderate amount, 4- A lot).
COMPLETED
NA
1348 participants
At 6- and 12-month follow-up visits with a sub-sample of participants
2022-11-09
Participant Flow
At the primary care site patients upon arrival were asked to complete screeners (for depression and problematic alcohol use). In the event of positive screen for depression and/or alcohol use problems, clinicians at site completed an in-depth diagnostic interview. Participants who met all inclusionary criteria were informed about this project and provided an informed consent form. Providers and administrators who worked for the site for at least 3 months were asked to participate.
Participant milestones
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
Providers in Digital Health Assisted Mental Healthcare Intervention
Providers at partnering primary care sites were all offered the opportunity to complete the implementation context and outcome measure in this research project at the time of implementation launch and at designated timepoints thereafter.
|
Administrative Staff in Digital Health Assisted Mental Healthcare Intervention
Administrative staff at partnering primary care sites were all offered the opportunity to complete the implementation context and outcome measure in this research project at the time of implementation launch and at designated timepoints thereafter.
|
|---|---|---|---|
|
Overall Study
STARTED
|
1264
|
45
|
39
|
|
Overall Study
COMPLETED
|
928
|
32
|
30
|
|
Overall Study
NOT COMPLETED
|
336
|
13
|
9
|
Reasons for withdrawal
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
Providers in Digital Health Assisted Mental Healthcare Intervention
Providers at partnering primary care sites were all offered the opportunity to complete the implementation context and outcome measure in this research project at the time of implementation launch and at designated timepoints thereafter.
|
Administrative Staff in Digital Health Assisted Mental Healthcare Intervention
Administrative staff at partnering primary care sites were all offered the opportunity to complete the implementation context and outcome measure in this research project at the time of implementation launch and at designated timepoints thereafter.
|
|---|---|---|---|
|
Overall Study
Lost to Follow-up
|
122
|
13
|
9
|
|
Overall Study
Death
|
4
|
0
|
0
|
|
Overall Study
Lack of Efficacy
|
29
|
0
|
0
|
|
Overall Study
Withdrawal by Subject
|
180
|
0
|
0
|
|
Overall Study
Adverse Event
|
1
|
0
|
0
|
Baseline Characteristics
This measure is not administered to providers and administrative staff.
Baseline characteristics by cohort
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=1264 Participants
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
Providers in Digital Health Assisted Mental Healthcare Intervention
n=45 Participants
Providers at partnering primary care sites were all offered the opportunity to complete the implementation context and outcome measure in this research project at the time of implementation launch and at designated timepoints thereafter.
|
Administrative Staff in Digital Health Assisted Mental Healthcare Intervention
n=39 Participants
Administrative staff at partnering primary care sites were all offered the opportunity to complete the implementation context and outcome measure in this research project at the time of implementation launch and at designated timepoints thereafter.
|
Total
n=1348 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
49.60 years
STANDARD_DEVIATION 17.28 • n=1264 Participants
|
32.87 years
STANDARD_DEVIATION 10.12 • n=45 Participants
|
36.39 years
STANDARD_DEVIATION 12.51 • n=39 Participants
|
48.88 years
STANDARD_DEVIATION 17.34 • n=1348 Participants
|
|
Sex: Female, Male
Female
|
969 Participants
n=1264 Participants
|
30 Participants
n=45 Participants
|
27 Participants
n=39 Participants
|
1026 Participants
n=1348 Participants
|
|
Sex: Female, Male
Male
|
295 Participants
n=1264 Participants
|
15 Participants
n=45 Participants
|
12 Participants
n=39 Participants
|
322 Participants
n=1348 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
991 Participants
n=1264 Participants
|
42 Participants
n=45 Participants
|
34 Participants
n=39 Participants
|
1067 Participants
n=1348 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
20 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
1 Participants
n=39 Participants
|
21 Participants
n=1348 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
253 Participants
n=1264 Participants
|
3 Participants
n=45 Participants
|
4 Participants
n=39 Participants
|
260 Participants
n=1348 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
23 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
1 Participants
n=39 Participants
|
24 Participants
n=1348 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
0 Participants
n=1348 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
0 Participants
n=1348 Participants
|
|
Race (NIH/OMB)
Black or African American
|
10 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
10 Participants
n=1348 Participants
|
|
Race (NIH/OMB)
White
|
232 Participants
n=1264 Participants
|
9 Participants
n=45 Participants
|
7 Participants
n=39 Participants
|
248 Participants
n=1348 Participants
|
|
Race (NIH/OMB)
More than one race
|
681 Participants
n=1264 Participants
|
22 Participants
n=45 Participants
|
23 Participants
n=39 Participants
|
726 Participants
n=1348 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
318 Participants
n=1264 Participants
|
14 Participants
n=45 Participants
|
8 Participants
n=39 Participants
|
340 Participants
n=1348 Participants
|
|
Region of Enrollment
Colombia
|
1264 participants
n=1264 Participants
|
45 participants
n=45 Participants
|
39 participants
n=39 Participants
|
1348 participants
n=1348 Participants
|
|
Name of Primary Care Center Site
Javesalud - Bogota
|
483 Participants
n=1264 Participants
|
13 Participants
n=45 Participants
|
12 Participants
n=39 Participants
|
508 Participants
n=1348 Participants
|
|
Name of Primary Care Center Site
Hospital Regional de Duitama
|
471 Participants
n=1264 Participants
|
14 Participants
n=45 Participants
|
6 Participants
n=39 Participants
|
491 Participants
n=1348 Participants
|
|
Name of Primary Care Center Site
Hospital Santa Rosa de Viterbo
|
196 Participants
n=1264 Participants
|
8 Participants
n=45 Participants
|
6 Participants
n=39 Participants
|
210 Participants
n=1348 Participants
|
|
Name of Primary Care Center Site
Hospital Granja de Lerida
|
27 Participants
n=1264 Participants
|
5 Participants
n=45 Participants
|
9 Participants
n=39 Participants
|
41 Participants
n=1348 Participants
|
|
Name of Primary Care Center Site
Hospital de Chaparral
|
78 Participants
n=1264 Participants
|
3 Participants
n=45 Participants
|
3 Participants
n=39 Participants
|
84 Participants
n=1348 Participants
|
|
Name of Primary Care Center Site
Hospital Armero Guayabal
|
9 Participants
n=1264 Participants
|
2 Participants
n=45 Participants
|
3 Participants
n=39 Participants
|
14 Participants
n=1348 Participants
|
|
Name of Primary Care Center Site
Prefer not to respond
|
0 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
0 Participants
n=1348 Participants
|
|
Education Level
None
|
34 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
34 Participants
n=1348 Participants
|
|
Education Level
Preschool
|
1 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
1 Participants
n=1348 Participants
|
|
Education Level
Kindergarten
|
0 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
0 Participants
n=1348 Participants
|
|
Education Level
Grade 1
|
64 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
64 Participants
n=1348 Participants
|
|
Education Level
Grade 2
|
71 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
71 Participants
n=1348 Participants
|
|
Education Level
Grade 3
|
72 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
72 Participants
n=1348 Participants
|
|
Education Level
Grade 4
|
47 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
47 Participants
n=1348 Participants
|
|
Education Level
Grade 5
|
178 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
178 Participants
n=1348 Participants
|
|
Education Level
Grade 6
|
36 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
36 Participants
n=1348 Participants
|
|
Education Level
Grade 7
|
43 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
43 Participants
n=1348 Participants
|
|
Education Level
Grade 8
|
31 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
31 Participants
n=1348 Participants
|
|
Education Level
Grade 9
|
40 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
40 Participants
n=1348 Participants
|
|
Education Level
Grade 10
|
17 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
17 Participants
n=1348 Participants
|
|
Education Level
Grade 11
|
21 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
21 Participants
n=1348 Participants
|
|
Education Level
Secondary Education Diploma
|
198 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
1 Participants
n=39 Participants
|
199 Participants
n=1348 Participants
|
|
Education Level
Technical Studies
|
149 Participants
n=1264 Participants
|
2 Participants
n=45 Participants
|
9 Participants
n=39 Participants
|
160 Participants
n=1348 Participants
|
|
Education Level
Less than one year of university
|
18 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
1 Participants
n=39 Participants
|
19 Participants
n=1348 Participants
|
|
Education Level
Diploma
|
4 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
4 Participants
n=1348 Participants
|
|
Education Level
University Degree
|
8 Participants
n=1264 Participants
|
2 Participants
n=45 Participants
|
1 Participants
n=39 Participants
|
11 Participants
n=1348 Participants
|
|
Education Level
Master's Degree
|
18 Participants
n=1264 Participants
|
13 Participants
n=45 Participants
|
12 Participants
n=39 Participants
|
43 Participants
n=1348 Participants
|
|
Education Level
Professional Degree
|
135 Participants
n=1264 Participants
|
28 Participants
n=45 Participants
|
14 Participants
n=39 Participants
|
177 Participants
n=1348 Participants
|
|
Education Level
Doctorate
|
1 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
1 Participants
n=1348 Participants
|
|
Education Level
At least one year in two-year university program
|
21 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
21 Participants
n=1348 Participants
|
|
Education Level
One year in four-year university program
|
13 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
13 Participants
n=1348 Participants
|
|
Education Level
Two years in four-year university program
|
9 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
9 Participants
n=1348 Participants
|
|
Education Level
At least three years in four-year university program
|
35 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
1 Participants
n=39 Participants
|
36 Participants
n=1348 Participants
|
|
Education Level
Unknown or prefers not to respond
|
0 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
0 Participants
n=1348 Participants
|
|
Socioeconomic Status
Rural Area
|
168 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
168 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Socioeconomic Status
Stratum 1
|
300 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
300 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Socioeconomic Status
Stratum 2
|
316 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
316 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Socioeconomic Status
Stratum 3
|
272 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
272 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Socioeconomic Status
Stratum 4
|
152 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
152 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Socioeconomic Status
Stratum 5
|
33 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
33 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Socioeconomic Status
Stratum 6
|
9 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
9 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Socioeconomic Status
Prefers not to respond
|
14 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
14 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Employment Status
Full-time Employed
|
171 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
171 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Employment Status
Self-employed
|
286 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
286 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Employment Status
Part-time Employed
|
49 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
49 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Employment Status
Unemployed, seeking jobs
|
112 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
112 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Employment Status
Unemployed, not seeking jobs
|
39 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
39 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Employment Status
Unable to work
|
25 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
25 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Employment Status
Pensioner
|
75 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
75 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Employment Status
Housekeeper
|
428 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
428 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Employment Status
Student
|
70 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
70 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Employment Status
Prefers not to respond
|
9 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
9 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Marital Status
Single
|
399 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
399 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Marital Status
Married or Free Union
|
544 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
544 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Marital Status
Separated
|
172 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
172 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Marital Status
Divorced
|
36 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
36 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Marital Status
Widowed
|
107 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
107 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Marital Status
Prefers not to respond
|
6 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
6 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Number of persons in household
0
|
130 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
130 Participants
n=1348 Participants
|
|
Number of persons in household
1
|
312 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
312 Participants
n=1348 Participants
|
|
Number of persons in household
2
|
277 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
277 Participants
n=1348 Participants
|
|
Number of persons in household
3
|
253 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
253 Participants
n=1348 Participants
|
|
Number of persons in household
4
|
148 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
148 Participants
n=1348 Participants
|
|
Number of persons in household
5
|
77 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
77 Participants
n=1348 Participants
|
|
Number of persons in household
6
|
33 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
33 Participants
n=1348 Participants
|
|
Number of persons in household
7
|
16 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
16 Participants
n=1348 Participants
|
|
Number of persons in household
8
|
8 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
8 Participants
n=1348 Participants
|
|
Number of persons in household
9
|
4 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
4 Participants
n=1348 Participants
|
|
Number of persons in household
10
|
1 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
1 Participants
n=1348 Participants
|
|
Number of persons in household
11
|
2 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
2 Participants
n=1348 Participants
|
|
Number of persons in household
12
|
1 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
1 Participants
n=1348 Participants
|
|
Number of persons in household
14
|
2 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
2 Participants
n=1348 Participants
|
|
Health Insurance Status
No insurance
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Health Insurance Status
Subsidized plan (ARS, SISBEN, EPS-S)
|
845 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
845 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Health Insurance Status
Contributory plan (EPS)
|
413 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
413 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Health Insurance Status
Indigenous Health plan
|
0 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Health Insurance Status
Supplemental plan or prepaid medical plan
|
4 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
4 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Health Insurance Status
Special plan (Armed Forces, Ecopetrol)
|
0 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Health Insurance Status
Prefers not to respond
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Length of time to reach healthcare center
0-29 minutes
|
631 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
631 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Length of time to reach healthcare center
30-59 minutes
|
464 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
464 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Length of time to reach healthcare center
60-120 minutes
|
134 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
134 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Length of time to reach healthcare center
More than 120 minutes
|
34 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
34 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Length of time to reach healthcare center
Prefers not to respond
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of previous depressive episodes
0 episodes
|
890 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
890 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of previous depressive episodes
1 episode
|
225 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
225 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of previous depressive episodes
2 episodes
|
70 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
70 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of previous depressive episodes
3 episodes
|
71 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
71 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of previous depressive episodes
Prefers not to respond
|
8 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
8 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
No traumatic events
|
500 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
500 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
1
|
372 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
372 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
2
|
199 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
199 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
3
|
83 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
83 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
4
|
37 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
37 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
5
|
24 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
24 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
6
|
10 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
10 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
7
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
9
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
10
|
6 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
6 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
History of Traumatic Events
Prefers not to respond
|
31 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
31 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Family History of Depression
Parents with depression
|
163 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
163 Participants
n=1348 Participants
|
|
Family History of Depression
Siblings with depression
|
133 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
133 Participants
n=1348 Participants
|
|
Family History of Depression
First degree relatives with depression
|
132 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
132 Participants
n=1348 Participants
|
|
Family History of Depression
No family history of depression
|
764 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
764 Participants
n=1348 Participants
|
|
Family History of Depression
Prefers not to respond
|
156 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
156 Participants
n=1348 Participants
|
|
Family History of Harmful Alcohol Use
Parents with harmful alcohol use
|
473 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
473 Participants
n=1348 Participants
|
|
Family History of Harmful Alcohol Use
Siblings with harmful alcohol use
|
356 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
356 Participants
n=1348 Participants
|
|
Family History of Harmful Alcohol Use
First degree relatives with harmful alcohol use
|
367 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
367 Participants
n=1348 Participants
|
|
Family History of Harmful Alcohol Use
No family history of harmful alcohol use
|
605 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
605 Participants
n=1348 Participants
|
|
Family History of Harmful Alcohol Use
Prefers not to respond
|
18 Participants
n=1264 Participants
|
0 Participants
n=45 Participants
|
0 Participants
n=39 Participants
|
18 Participants
n=1348 Participants
|
|
Smartphone Use
Yes - has a smartphone.
|
882 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
882 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Smartphone Use
No - does not have a smartphone
|
382 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
382 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Internet Use
Yes, uses the Internet
|
843 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
843 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Internet Use
No, does not use the Internet
|
421 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
421 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Tobacco Use
Current smoker
|
163 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
163 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Tobacco Use
Former smoker
|
414 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
414 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Tobacco Use
Never smoked
|
686 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
686 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Tobacco Use
Prefers not to respond
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Antidepressants Use
Yes
|
187 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
187 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Antidepressants Use
No
|
1075 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1075 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Antidepressants Use
Prefers not to respond
|
2 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
2 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Psychotherapy Treatment Use
Yes
|
213 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
213 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Psychotherapy Treatment Use
No
|
1048 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1048 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Psychotherapy Treatment Use
Prefers not to respond
|
3 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
3 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Alcoholics Anonymous
Yes
|
12 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
12 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Alcoholics Anonymous
No
|
1252 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1252 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Alcoholics Anonymous
Prefers not to respond
|
0 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Medication for controlling problematic alcohol use
Yes
|
2 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
2 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Medication for controlling problematic alcohol use
No
|
1262 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1262 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Medication for controlling problematic alcohol use
Prefers not to respond
|
0 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Substance Use
Tobacco
|
163 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
163 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Substance Use
Cannabis
|
53 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
53 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Substance Use
Cocaine
|
7 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
7 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Substance Use
Prescription Stimulants
|
2 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
2 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Substance Use
Methamphetamine
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Substance Use
Sedatives
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Substance Use
Hallucinogens
|
5 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
5 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Substance Use
Street Opioids
|
0 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
|
Substance Use
Prescription Opioids
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
0 Participants
This measure is not administered to providers and administrative staff.
|
1 Participants
n=1264 Participants • This measure is not administered to providers and administrative staff.
|
PRIMARY outcome
Timeframe: At 6- and 12-month follow-up visits with a sub-sample of participantsThis measure consists of 5 scales: Adoption, Appropriateness, Acceptability, Feasibility, and Reach/Access. All four scales have a range of 1 to 4 (1- Not at all, 2- A little bit, 3- A moderate amount, 4- A lot).
Outcome measures
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=166 Participants
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Consumer Instrument
6-month follow-up Adoption
|
2.76 score on a scale
Standard Deviation 0.58
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Consumer Instrument
6-month follow-up Acceptability
|
3.22 score on a scale
Standard Deviation 0.64
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Consumer Instrument
6-month follow-up Appropriateness
|
3.21 score on a scale
Standard Deviation 0.64
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Consumer Instrument
6-month follow-up Feasibility
|
2.91 score on a scale
Standard Deviation 0.62
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Consumer Instrument
6-month follow-up Reach/Access
|
2.59 score on a scale
Standard Deviation 0.69
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Consumer Instrument
12-month follow-up Adoption
|
3.05 score on a scale
Standard Deviation 0.62
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Consumer Instrument
12-month follow-up Acceptability
|
3.27 score on a scale
Standard Deviation 0.61
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Consumer Instrument
12-month follow-up Appropriateness
|
3.28 score on a scale
Standard Deviation 0.50
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Consumer Instrument
12-month follow-up Feasibility
|
2.93 score on a scale
Standard Deviation 0.54
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Consumer Instrument
12-month follow-up Reach/Access
|
2.67 score on a scale
Standard Deviation 0.66
|
PRIMARY outcome
Timeframe: At the time of the provider training, 6 months, 12 months, 18 months, and 24 months.Population: The study implementation timeline was designed to have staggered launch dates for the six sites. Specifically, Javesalud (Site 1) and Santa Rosa (Site 2) launched first and were able to complete all follow-ups. Tundama (Site 3) was only able to complete through 18-month follow-ups. Guasca (Site 4) and Armero (Site 5) were only able to complete through 12-month follow-ups. Soacha (Site 6) was only able to complete through the 6-month follow-ups.
This measure consists of 8 scales: Adoption, Appropriateness, Feasibility, Reach/Access, Organizational climate, Leadership in Implementing, and General Leadership Skills. All eight scales have a range of 1 to 4 (1- Not at all, 2- A little bit, 3- A moderate amount, 4- A lot).
Outcome measures
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=24 Participants
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Adoption at Baseline
|
2.95 score on a scale
Standard Deviation 0.55
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Adoption at 6 months
|
2.65 score on a scale
Standard Deviation 0.61
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Adoption at 12 months
|
2.93 score on a scale
Standard Deviation 0.43
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Adoption at 18 months
|
2.92 score on a scale
Standard Deviation 0.51
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Adoption at 24 months
|
2.85 score on a scale
Standard Deviation 0.68
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Accessibility at Baseline
|
3.41 score on a scale
Standard Deviation 0.51
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Accessibility at 6 months
|
3.35 score on a scale
Standard Deviation 0.45
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Accessibility at 12 months
|
3.50 score on a scale
Standard Deviation 0.47
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Accessibility at 18 months
|
3.55 score on a scale
Standard Deviation 0.32
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Accessibility at 24 months
|
3.38 score on a scale
Standard Deviation 0.44
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Appropriateness at Baseline
|
3.40 score on a scale
Standard Deviation 0.34
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Appropriateness at 6 months
|
3.32 score on a scale
Standard Deviation 0.47
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Appropriateness at 12 months
|
3.52 score on a scale
Standard Deviation 0.31
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Appropriateness at 18 months
|
3.41 score on a scale
Standard Deviation 0.42
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Appropriateness at 24 months
|
3.16 score on a scale
Standard Deviation 0.48
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Feasibility at Baseline
|
2.94 score on a scale
Standard Deviation 0.55
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Feasibility at 6 months
|
2.88 score on a scale
Standard Deviation 0.38
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Feasibility at 12 months
|
2.72 score on a scale
Standard Deviation 0.40
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Feasibility at 18 months
|
3.01 score on a scale
Standard Deviation 0.31
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Feasibility at 24 months
|
2.84 score on a scale
Standard Deviation 0.63
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Resources at Baseline
|
3.14 score on a scale
Standard Deviation 0.65
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Resources at 6 months
|
3.08 score on a scale
Standard Deviation 0.42
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Resources at 12 months
|
2.98 score on a scale
Standard Deviation 0.47
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Resources at 18 months
|
3.17 score on a scale
Standard Deviation 0.44
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Resources at 24 months
|
3.14 score on a scale
Standard Deviation 0.64
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Reach/Access at Baseline
|
2.78 score on a scale
Standard Deviation 0.65
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Reach/Access at 6 months
|
2.85 score on a scale
Standard Deviation 0.48
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Reach/Access at 12 months
|
2.96 score on a scale
Standard Deviation 0.44
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Reach/Access at 18 months
|
3.00 score on a scale
Standard Deviation 0.52
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Reach/Access at 24 months
|
2.91 score on a scale
Standard Deviation 0.22
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Organizational Climate at Baseline
|
3.42 score on a scale
Standard Deviation 0.44
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Organizational Climate at 6 months
|
3.43 score on a scale
Standard Deviation 0.43
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Organizational Climate at 12 months
|
3.56 score on a scale
Standard Deviation 0.30
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Organizational Climate at 18 months
|
3.60 score on a scale
Standard Deviation 0.35
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Organizational Climate at 24 months
|
3.43 score on a scale
Standard Deviation 0.61
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Leadership in Implementing at Baseline
|
3.38 score on a scale
Standard Deviation 0.65
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Leadership in Implementing at 6 months
|
3.24 score on a scale
Standard Deviation 0.64
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Leadership in Implementing at 12 months
|
3.46 score on a scale
Standard Deviation 0.41
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Leadership in Implementing at 18 months
|
3.57 score on a scale
Standard Deviation 0.44
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
Leadership in Implementing at 24 months
|
3.06 score on a scale
Standard Deviation 0.86
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
General Leadership Skills at Baseline
|
3.32 score on a scale
Standard Deviation 0.67
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
General Leadership Skills at 6 months
|
3.36 score on a scale
Standard Deviation 0.55
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
General Leadership Skills at 12 months
|
3.48 score on a scale
Standard Deviation 0.45
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
General Leadership Skills at 18 months
|
3.48 score on a scale
Standard Deviation 0.50
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Provider Instrument
General Leadership Skills at 24 months
|
3.20 score on a scale
Standard Deviation 0.94
|
PRIMARY outcome
Timeframe: At the time of the staff training, 6 months, 12 months, 18 months, and 24 months.Population: The study implementation timeline was designed to have staggered launch dates for the six sites. Specifically, Javesalud (Site 1) and Santa Rosa (Site 2) launched first and were able to complete all follow-ups. Tundama (Site 3) was only able to complete through 18-month follow-ups. Guasca (Site 4) and Armero (Site 5) were only able to complete through 12-month follow-ups. Soacha (Site 6) was only able to complete through the 6-month follow-ups.
This measure consists of 9 scales: 1) Adoption, Appropriateness, Acceptability, Feasibility, Reach/Access, Organizational climate, Leadership in Implementing, General Leadership Skills, and Knowledge. All nine scales have a range of 1 to 4 (1- Not at all, 2- A little bit, 3- A moderate amount, 4- A lot).
Outcome measures
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=27 Participants
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Knowledge at Baseline
|
1.95 score on a scale
Standard Deviation 0.48
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Adoption at Baseline
|
3.38 score on a scale
Standard Deviation 0.47
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Adoption at 6 months
|
3.37 score on a scale
Standard Deviation 0.46
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Adoption at 12 months
|
3.69 score on a scale
Standard Deviation 0.40
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Adoption at 18 months
|
3.87 score on a scale
Standard Deviation 0.22
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Adoption at 24 months
|
3.50 score on a scale
Standard Deviation 0.67
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Accessibility at Baseline
|
3.77 score on a scale
Standard Deviation 0.37
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Accessibility at 6 months
|
3.50 score on a scale
Standard Deviation 0.39
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Accessibility at 12 months
|
3.50 score on a scale
Standard Deviation 0.42
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Accessibility at 18 months
|
3.60 score on a scale
Standard Deviation 0.42
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Accessibility at 24 months
|
3.39 score on a scale
Standard Deviation 0.55
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Appropriateness at Baseline
|
3.54 score on a scale
Standard Deviation 0.37
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Appropriateness at 6 months
|
2.77 score on a scale
Standard Deviation 0.89
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Appropriateness at 12 months
|
2.99 score on a scale
Standard Deviation 0.55
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Appropriateness at 18 months
|
3.19 score on a scale
Standard Deviation 0.53
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Appropriateness at 24 months
|
3.07 score on a scale
Standard Deviation 0.55
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Feasibility at Baseline
|
2.88 score on a scale
Standard Deviation 0.60
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Feasibility at 6 months
|
3.17 score on a scale
Standard Deviation 0.52
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Feasibility at 12 months
|
2.96 score on a scale
Standard Deviation 0.55
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Feasibility at 18 months
|
3.20 score on a scale
Standard Deviation 0.49
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Feasibility at 24 months
|
3.17 score on a scale
Standard Deviation 0.59
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Reach/Access at Baseline
|
2.93 score on a scale
Standard Deviation 0.58
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Reach/Access at 6 months
|
3.41 score on a scale
Standard Deviation 0.62
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Reach/Access at 12 months
|
3.47 score on a scale
Standard Deviation 0.54
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Reach/Access at 18 months
|
3.70 score on a scale
Standard Deviation 0.35
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Reach/Access at 24 months
|
3.58 score on a scale
Standard Deviation 0.27
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Organizational Climate at Baseline
|
3.39 score on a scale
Standard Deviation 0.43
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Organizational Climate at 6 months
|
3.20 score on a scale
Standard Deviation 0.77
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Organizational Climate at 12 months
|
3.22 score on a scale
Standard Deviation 0.63
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Organizational Climate at 18 months
|
3.52 score on a scale
Standard Deviation 0.64
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Organizational Climate at 24 months
|
3.47 score on a scale
Standard Deviation 0.48
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Leadership in Implementing at Baseline
|
3.29 score on a scale
Standard Deviation 0.69
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Leadership in Implementing at 6 months
|
3.17 score on a scale
Standard Deviation 0.78
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Leadership in Implementing at 12 months
|
3.25 score on a scale
Standard Deviation 0.80
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Leadership in Implementing at 18 months
|
3.65 score on a scale
Standard Deviation 0.37
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Leadership in Implementing at 24 months
|
3.47 score on a scale
Standard Deviation 0.45
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
General Leadership Skills at Baseline
|
3.34 score on a scale
Standard Deviation 0.56
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
General Leadership Skills at 6 months
|
2.42 score on a scale
Standard Deviation 1.02
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
General Leadership Skills at 12 months
|
2.92 score on a scale
Standard Deviation 0.81
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
General Leadership Skills at 18 months
|
2.44 score on a scale
Standard Deviation 0.63
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
General Leadership Skills at 24 months
|
2.80 score on a scale
Standard Deviation 1.05
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Knowledge at 6 months
|
1.95 score on a scale
Standard Deviation 0.28
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Knowledge at 12 months
|
1.92 score on a scale
Standard Deviation 0.27
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Knowledge at 18 months
|
1.91 score on a scale
Standard Deviation 0.26
|
|
The Integrated Measure of Implementation Context and Outcomes as a Change Over Time in Low and Middle Income Countries Organizational Staff Instrument
Knowledge at 24 months
|
1.92 score on a scale
Standard Deviation 0.26
|
PRIMARY outcome
Timeframe: At the time of the provider training, 6 months, 12 months, 18 months, and 24 months.Population: The study implementation timeline was designed to have staggered launch dates for the six sites. For providers/staff, not all sites completed 18 and 24-month follow-up assessments. Also, baseline data is collected prior to site implementation launch. Some providers/administrators consented and provided data (at various follow-up times) after baseline implementation data collection took place at the sites.
This instrument was developed from the Program Sustainability Assessment and consists of 7 scales: Environmental Support, Partnerships, Organizational Capacity, Program Evaluation, Program Adaptation, Communication with Public, and Communications within the organization. All scales have a range of 1 to 4 (1- Not at all, 2- A little bit, 3- A moderate amount, 4- A lot). The seven sub-scales are combined to an overall score by averaging the sub-scale scores. The computed overall scales have a range of 1 to 4.
Outcome measures
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=41 Participants
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
The Program Sustainability Assessment Tool (PSAT) Providers
Baseline overall
|
3.01 score on a scale
Standard Deviation 0.61
|
|
The Program Sustainability Assessment Tool (PSAT) Providers
6 months follow-up overall
|
2.91 score on a scale
Standard Deviation 0.63
|
|
The Program Sustainability Assessment Tool (PSAT) Providers
12 months follow-up overall
|
2.99 score on a scale
Standard Deviation 0.41
|
|
The Program Sustainability Assessment Tool (PSAT) Providers
18 months follow-up overall
|
3.01 score on a scale
Standard Deviation 0.51
|
|
The Program Sustainability Assessment Tool (PSAT) Providers
24 months follow-up overall
|
2.82 score on a scale
Standard Deviation 0.63
|
PRIMARY outcome
Timeframe: At the time of the staff training, 6 months, 12 months, 18 months, and 24 months.Population: The study implementation timeline was designed to have staggered launch dates for the six sites. For providers/staff, not all sites completed 18 and 24-month follow-up assessments. Also, baseline data was collected prior to site implementation launch. Some providers/administrators consented and provided data (at various follow-up times) after baseline implementation data collection took place at the sites.
This instrument was developed from the Program Sustainability Assessment and consists of 7 scales: Environmental Support, Funding Stability, Partnerships, Organizational Capacity, Program Evaluation, Program Adaptation, Communication with Public, Communications within the organization, and Communication with Government. All seven scales have a range of 1 to 4 (1- Not at all, 2- A little bit, 3- A moderate amount, 4- A lot). The seven sub-scales are combined to an overall score by averaging the sub-scale scores. The computed overall scales have a range of 1 to 4.
Outcome measures
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=30 Participants
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
The Program Sustainability Assessment Tool (PSAT) Administrative Staff
Baseline overall
|
2.72 score on a scale
Standard Deviation 0.58
|
|
The Program Sustainability Assessment Tool (PSAT) Administrative Staff
6 months follow-up overall
|
3.14 score on a scale
Standard Deviation 0.37
|
|
The Program Sustainability Assessment Tool (PSAT) Administrative Staff
12 months follow-up overall
|
3.23 score on a scale
Standard Deviation 0.27
|
|
The Program Sustainability Assessment Tool (PSAT) Administrative Staff
18 months follow-up overall
|
3.41 score on a scale
Standard Deviation 0.29
|
|
The Program Sustainability Assessment Tool (PSAT) Administrative Staff
24 months follow-up overall
|
3.32 score on a scale
Standard Deviation 0.32
|
SECONDARY outcome
Timeframe: This patient measure were assessed at baseline and every 3 months thereafter for a period of 12 months (for a total of 5 assessment timepoints per patient).Population: Only patient participants with a depression diagnosis completed the PHQ assessment at all timepoints. The number of participants analyzed varies at each assessment timepoint due to participants unable to reach during the window of follow-up and participants who withdrew from the study.
A measure with 8 items used to assess depression. The total score of the scale ranges from 0 to 24, with 0 representing no significant depressive symptoms and 24 representing the most severe depressive symptoms.
Outcome measures
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=1214 Participants
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
Patient Health Questionnaire (PHQ-8)
12-Month
|
4.67 score on a scale
Standard Deviation 4.38
|
|
Patient Health Questionnaire (PHQ-8)
Baseline
|
11.32 score on a scale
Standard Deviation 5.07
|
|
Patient Health Questionnaire (PHQ-8)
3-Month
|
5.82 score on a scale
Standard Deviation 5.09
|
|
Patient Health Questionnaire (PHQ-8)
6-Month
|
5.51 score on a scale
Standard Deviation 4.94
|
|
Patient Health Questionnaire (PHQ-8)
9-Month
|
5.37 score on a scale
Standard Deviation 4.67
|
SECONDARY outcome
Timeframe: This patient measure were assessed at baseline and every 3 months for a period of 12 months (for a total of 5 assessment timepoints-level assessments per patient).Population: The number of participants analyzed differs at each assessment timepoint due to a number of participants who were unable to reach during the designated window of assessment and participants who actively withdrew from the study for various non-safety related reasons.
The WHODAS 2.0 assesses health-related difficulties across six different domains of functioning (cognition, mobility, self-care, socializing, life activities, and participation) that are linked conceptually and operationally to the International Classification of Functioning, Disability and Health (ICF). The scores assigned to 12 items are - "none" (1), "mild" (2) "moderate" (3), "severe" (4) and "extreme" (5). The scores for the 12 items are summed into a total score ranging from 12 (least severe) to 50 (most severe). The last 3 items of the assessment collect the number of days the reported health-related difficulties impact the participants in the past 90 days.
Outcome measures
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=1264 Participants
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS)
Baseline Total Sum Score
|
23.07 score on a scale
Standard Deviation 7.72
|
|
12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS)
3-Month Total Sum Score
|
19.55 score on a scale
Standard Deviation 7.30
|
|
12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS)
6-Month Total Sum Score
|
19.32 score on a scale
Standard Deviation 7.50
|
|
12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS)
9-Month Total Sum Score
|
18.87 score on a scale
Standard Deviation 6.98
|
|
12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS)
12-Month Total Sum Score
|
18.59 score on a scale
Standard Deviation 6.73
|
SECONDARY outcome
Timeframe: This patient measure were assessed at baseline and every 3 months for a period of 12 months (for a total of 5 assessment timepoints per patient).Population: Number of participants analyzed differ at each assessment timepoint because some participants were unable to be reached during the designated window of follow-up and some participants withdrew from the study.
The GAD-7 is a 7-item self-reported screening questionnaire that has been validated to assess for generalized anxiety disorder (GAD) in outpatient and primary care settings. The measure is scored from 0 to 21, with 0 meaning minimal anxiety and 21 meaning most severe anxiety.
Outcome measures
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=1264 Participants
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
General Anxiety Disorder Screener (GAD-7)
Baseline
|
9.11 score on a scale
Standard Deviation 5.43
|
|
General Anxiety Disorder Screener (GAD-7)
3-Month
|
5.21 score on a scale
Standard Deviation 4.65
|
|
General Anxiety Disorder Screener (GAD-7)
6-Month
|
4.63 score on a scale
Standard Deviation 4.35
|
|
General Anxiety Disorder Screener (GAD-7)
9-Month
|
4.05 score on a scale
Standard Deviation 3.97
|
|
General Anxiety Disorder Screener (GAD-7)
12-Month
|
3.34 score on a scale
Standard Deviation 3.69
|
SECONDARY outcome
Timeframe: At baseline and every 3 months for a period of 12 months (for a total of 5 assessment timepoints per patient with implementation study participants).Population: The overall number of participants is different from the overall number of the patients arm, because this assessment was only administered to patients diagnosed with alcohol use disorder. There are different numbers of participants analyzed at each timepoint due to a number of participants who were unable to be reached in the designated window of follow-up and who withdrew from the study.
The Quick Drinking Screen (QDS) is a 3-item questionnaire which asks about average drinking habits over the last ninety days. The responses are used to calculate the number of standard drinks consumed per week. In this measure, a standard drink is defined as 1-12 oz. regular can or glass of beer, or 1-5 oz. glass of regular wine, or 1 ½ oz. of regular proof hard liquor or spirits. Patients with alcohol use disorder will be asked to complete this measure as part of the baseline assessment and at every 3 months follow-up (a total of 5 assessment timepoints).
Outcome measures
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=168 Participants
Patients were offered a multi-component model of science-based mental health care. All participants who consented to participate were given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site showed them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program secondarily focused on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
The Quick Drinking Screen (QDS) (for Full Implementation Study Only)
Baseline Standard Drinks per Week
|
22.74 standard drinks per week
Standard Deviation 28.28
|
|
The Quick Drinking Screen (QDS) (for Full Implementation Study Only)
3-Month Standard Drinks per Week
|
35.20 standard drinks per week
Standard Deviation 96.14
|
|
The Quick Drinking Screen (QDS) (for Full Implementation Study Only)
6-Month Standard Drinks per Week
|
46.37 standard drinks per week
Standard Deviation 102.00
|
|
The Quick Drinking Screen (QDS) (for Full Implementation Study Only)
9-Month Standard Drinks per Week
|
38.11 standard drinks per week
Standard Deviation 80.02
|
|
The Quick Drinking Screen (QDS) (for Full Implementation Study Only)
12-Month Standard Drinks per Week
|
25.33 standard drinks per week
Standard Deviation 72.61
|
OTHER_PRE_SPECIFIED outcome
Timeframe: This patient measure will be assessed at baseline and every 3 months for a period of 12 months (for a total of 5 assessment timepoints per patient with pilot participants).The EQ-5D. The EQ-5D is a standardized instrument that has been widely used and validated within Spanish speaking populations from several countries in Latin America, and assesses 5 key dimensions of health.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: This patient measure will be assessed at baseline and every 3 months for a period of 12 months (for a total of 5 assessment timepoints per patient with pilot participants).The EQ-VAS assess health-related quality of life. The EQ-VAS asks "how good or bad your health is today?" The scale ranges from 0 (worst health imaginable) to 100 (best health imaginable). The participants marks their number with an "X" on the scale and writes it in a box.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: This patient measure will be assessed at baseline and every 3 months for a period of 12 months (for a total of 5 assessment timepoints per patient with pilot participants).A measure used to assess problematic alcohol use. The Alcohol TLFB asks patients about their alcohol use in the past 30 days.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Approximately every year prior to the time of implementation launch at a given site (starting with baseline in late 2017); at the time of implementation launch; and approximately every year thereafter at each site until study completion (April 2021).The BHIMC is an organizational measure of the level of behavioral health integration in medical practice settings. It evaluates policy, clinical practice and workforce dimensions of integration using mixed methods, i.e. combination of document review and observation.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Approximately every year prior to the time of implementation launch at a given site (starting with baseline in late 2017); at the time of implementation launch; and approximately every year thereafter at each site until study completion (April 2021).The TDABC method measures costs of implementing the proposed model of care for depression and alcohol use disorders.The TDABC method will be used to determine the costs of the specific human, equipment, and facility resources used for delivering mental health care to patients as part of the model of care.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: At baseline and every 3 months for a period of 12 months (for a total of 5 assessment timepoints per patient).The NSOMS assesses patients' medical resource use that is not part of the intervention, including non-treatment therapy visits, physician visits, residential and/or hospital detoxification, hospital and emergency department visits, and medication use through patient self-report.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: At baseline and every 3 months for a period of 12 months (for a total of 5 assessment timepoints per patient).The NMED assesses the non-medical costs of depression. This measure is in Spanish and has been used in Latin America and used by our team at Javeriana.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: At baseline, 6-month follow-ups, and 12-month follow-ups (for a total of 3 assessment timepoints per patient).The HPQ was developed by the World Health Organization, and assess the impact of depression on work performance (including sickness absence, presenteeism, and critical incidents).
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: At 3- and 6-months post-implementation (+/- a 2 week window around the targeted data collection date)Administrative interviews will assess implementation experiences, challenges to implementation and strategies used to facilitate implementation with different patient populations, changes made to workflow with use of the intervention, and salience of monitoring and feedback processes to inform providers and other stakeholders about the implementation success (approx. 5 at each site). The investigators will also assess the extent to which patients initiated use of the program via inquiry of their providers after learning of the program through patient channels.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: At 3- and 6-months post-implementation (+/- a 2 week window around the targeted data collection date)The investigators will recruit and follow a sample of patients (approx. 5 at each site) during the implementation project to explore feasibility issues regarding use, barriers and facilitating strategies for using the program, optimal dissemination strategies for promoting use of the program, and overall experiences using the program over time. These patient participants will be encouraged to document their experiences with the mental health service delivery model in an ongoing manner (e.g., note jotting, pictures, audio recording).
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: At 3- and 6-months post-implementation (+/- a 2 week window around the targeted data collection date)Provider interviews will assess implementation experiences, challenges to implementation and strategies used to facilitate implementation with different patient populations, changes made to workflow with use of the intervention, and salience of monitoring and feedback processes to inform providers and other stakeholders about the implementation success (approx. 5 at each site). The investigators will also assess the extent to which patients initiated use of the program via inquiry of their providers after learning of the program through patient channels.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Patients will be assessed once at a follow-up visit every 3 months or at a separately scheduled visit. Providers and administrators will be assessed once at a follow-up visit every 6 months or at a separate visit.The COVID-19 Impact Survey is a self-reported questionnaire developed by the NIMH U19 Scale-Up Hubs and will assess the impact of COVID-19 among patients, providers, and administrators enrolled in this study. Given the unknown and widespread implications of the COVID-19 pandemic in Colombia, it is critical to understand the context of COVID-19 for interpreting the study's findings.
Outcome measures
Outcome data not reported
Adverse Events
Patients in Digital Health Assisted Mental Healthcare Intervention
Serious adverse events
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=1264 participants at risk
Patients will be offered a multi-component model of science-based mental health care. All participants who consent to participate will be given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site will show them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program will secondarily focus on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
Endocrine disorders
Thyroidectomy
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Gastrointestinal disorders
Removal of Gallbladder
|
0.32%
4/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Catheterization
|
0.16%
2/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Gastrointestinal disorders
Liver Complications
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Psychiatric disorders
Suicidality
|
2.2%
28/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Nervous system disorders
Paralysis due to Parkinson's Disease
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Gastrointestinal disorders
Hospitalization due to Diarrhea
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Cardiac disorders
Chest Pain
|
0.40%
5/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Blood and lymphatic system disorders
Hospitalization due to Hyperglycemia
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Spinal Surgery
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Cardiac disorders
Heart Dysfunction
|
0.63%
8/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Renal and urinary disorders
Renal Procedure
|
0.16%
2/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Injury, poisoning and procedural complications
Broken Limb
|
0.32%
4/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Respiratory, thoracic and mediastinal disorders
Pneumonia
|
0.16%
2/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Colon Procedure
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Breast Cancer Related Surgery and Treatment
|
0.24%
3/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Infections and infestations
Shingles
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Psychiatric disorders
Manic Episode
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Total Knee Replacement
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Caesarean Section Procedure
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary Embolism
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Nervous system disorders
Epilepsy
|
0.24%
3/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Infections and infestations
Urinary Tract Infection
|
0.24%
3/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Infections and infestations
Infection in Leg
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Nervous system disorders
Facial Paralysis
|
0.24%
3/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Curettage Biopsy
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Hernia Repair
|
0.24%
3/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Cancer
|
0.47%
6/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Psychiatric disorders
Worsening Depression without Suicidality
|
0.24%
3/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Surgery for Hand Trauma
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Blood and lymphatic system disorders
Blood Transfusion for Anemia
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
General disorders
Cysts
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Hip Replacement
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Endoscopic retrograde cholangiopancreatography
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Infections and infestations
Hospitalization due to COVID-19 Infection
|
1.7%
21/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Musculoskeletal and connective tissue disorders
Herniated Disc
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Arthroscopy Procedure
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Appendectomy
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
General disorders
Gastritis
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Surgical and medical procedures
Abdominal Pain
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
Other adverse events
| Measure |
Patients in Digital Health Assisted Mental Healthcare Intervention
n=1264 participants at risk
Patients will be offered a multi-component model of science-based mental health care. All participants who consent to participate will be given access to the mobile therapeutic tool based on the novel mobile-based platform (Laddr® from Square2 Systems). A trained staff member at the primary care site will show them how to use the tool.
Laddr is a mobile behavioral health technology that offers science-based self-regulation monitoring and health behavior change tools via an integrated platform to a wide array of populations. The program will secondarily focus on problematic alcohol use and its relationship to depression management.
|
|---|---|
|
Psychiatric disorders
Medical appointment due to non-serious diagnosis related symptoms
|
31.9%
403/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Infections and infestations
COVID-19 Infection
|
6.6%
84/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
General disorders
Headaches
|
0.32%
4/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Nervous system disorders
Vertigo Episode
|
0.16%
2/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Resection of Malignant Mass on Face
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Nervous system disorders
Displacement and imbalance
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Nervous system disorders
Facial Paralysis
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
General disorders
Fever and face rash
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Blood and lymphatic system disorders
Complication of chronic venous insufficiency
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Psychiatric disorders
Worsening of Depressive Symptoms
|
1.8%
23/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Psychiatric disorders
Panic attack
|
0.79%
10/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Psychiatric disorders
Suicide ideation with risk of self-harm
|
0.55%
7/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Psychiatric disorders
Worsening of depression symptoms secondary to autoimmune disease complication
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Psychiatric disorders
Parasuicide behavior
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Pregnancy, puerperium and perinatal conditions
Pregnancy
|
0.87%
11/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Reproductive system and breast disorders
Excision of Uterine Fibroid
|
0.16%
2/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Reproductive system and breast disorders
Tubal ligation surgery
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Reproductive system and breast disorders
Ovary and thyroid cysts
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Reproductive system and breast disorders
Excision of ovarian myoma
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Reproductive system and breast disorders
Post-abortion difficulties
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Pregnancy, puerperium and perinatal conditions
Pregnancy miscarriage
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Pregnancy, puerperium and perinatal conditions
Bleeding related to pregnancy
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Reproductive system and breast disorders
Vaginal bleeding
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Reproductive system and breast disorders
Resection of endometrial polyps
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Injury, poisoning and procedural complications
Trauma related to fall injuries
|
0.55%
7/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Injury, poisoning and procedural complications
Work accident
|
0.16%
2/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Injury, poisoning and procedural complications
Accident under alcohol influence
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Eye disorders
Eye Procedure
|
0.40%
5/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Eye disorders
Ocular hemorrhage
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Gastrointestinal disorders
Abdominal pain
|
0.24%
3/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Gastrointestinal disorders
Food poisoning
|
0.24%
3/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Gastrointestinal disorders
Gastritis
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Gastrointestinal disorders
Resection of Gastric and Duodenal Polyps
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Gastrointestinal disorders
Stomach virus
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Gastrointestinal disorders
Liquid stools
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Gastrointestinal disorders
Gastric ulcer
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory problems
|
0.24%
3/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Respiratory, thoracic and mediastinal disorders
Acute bronchitis
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Cardiac disorders
Chest pain
|
0.24%
3/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Cardiac disorders
Pacemaker procedure
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Cardiac disorders
Arrythmia Tachycardia
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Cardiac disorders
Hypertension
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Cardiac disorders
Varicose Vein Surgery
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Cardiac disorders
Heart murmur
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Injury, poisoning and procedural complications
Ankle trauma
|
0.16%
2/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Musculoskeletal and connective tissue disorders
Mild Carpal Tunnel
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Musculoskeletal and connective tissue disorders
Hyperextension in Spine
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Musculoskeletal and connective tissue disorders
Broken Finger
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Musculoskeletal and connective tissue disorders
Spinal surgery
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Musculoskeletal and connective tissue disorders
Broken arm
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Musculoskeletal and connective tissue disorders
Knee pain
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Musculoskeletal and connective tissue disorders
Muscle Pain
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Musculoskeletal and connective tissue disorders
Vocal cords surgery
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Renal and urinary disorders
Diabetes diagnosis
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Renal and urinary disorders
Kidney stone
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Renal and urinary disorders
Urinary tract infection
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Endocrine disorders
Tiroidectomy
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
|
Endocrine disorders
Biopsy of thyroid nodules
|
0.08%
1/1264 • 12 months after baseline assessment.
The study collected and reported adverse events only for patient participants. Adverse event collection was not conducted for providers and administrators.
|
Additional Information
Lisa A. Marsch, PhD
Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place